Home » Stocks » SIGA

SIGA Technologies Inc. (SIGA)

Stock Price: $6.50 USD 0.03 (0.46%)
Updated Feb 24, 2021 3:59 PM EST - Market closed
Market Cap 506.97M
Revenue (ttm) 91.49M
Net Income (ttm) 31.68M
Shares Out 78.08M
EPS (ttm) 0.39
PE Ratio 16.80
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day February 24
Last Price $6.50
Previous Close $6.47
Change ($) 0.03
Change (%) 0.46%
Day's Open 6.49
Day's Range 6.43 - 6.63
Day's Volume 215,649
52-Week Range 3.96 - 8.10

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GuruFocus - 3 days ago

If you want to increase your chances of beating the market, one method is to select stocks that rank highly according to the "Magic Formula" criteria.

Other stocks mentioned: ENDP, GIB
GlobeNewsWire - 1 month ago

Second Contract by a Canadian Governmental Agency for the Procurement of Oral TPOXX

GlobeNewsWire - 3 months ago

NEW YORK, Nov. 12, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...

Seeking Alpha - 3 months ago

SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q3 2020 Results - Earnings Call Transcript

GlobeNewsWire - 3 months ago

- Third Quarter includes Delivery of Approximately 134,000 Courses of TPOXX® to U.S. Government –

GlobeNewsWire - 3 months ago

NEW YORK, Oct. 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...

GlobeNewsWire - 4 months ago

NEW YORK, Oct. 08, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that...

GlobeNewsWire - 5 months ago

NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced t...

GlobeNewsWire - 5 months ago

NEW YORK, Aug. 31, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

Seeking Alpha - 6 months ago

SIGA Technologies' (SIGA) CEO Phil Gomez on Q2 2020 Results - Earnings Call Transcript

GlobeNewsWire - 6 months ago

- Second Quarter includes Deliveries to SNS and First International Delivery -

GlobeNewsWire - 6 months ago

NEW YORK, July 30, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

GlobeNewsWire - 6 months ago

- Broader Indication to Include Smallpox, Monkeypox, Cowpox, and Vaccinia Complications -

GlobeNewsWire - 7 months ago

First Deliveries of Contract Option Exercises Announced in April 2020

GlobeNewsWire - 8 months ago

NEW YORK, June 15, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

GlobeNewsWire - 8 months ago

- 2,500 Courses Delivered to the Canadian Department of National Defence -

Seeking Alpha - 9 months ago

SIGA Technologies, Inc. (SIGA) CEO Phillip Gomez on Q1 2020 Results - Earnings Call Transcript

GlobeNewsWire - 9 months ago

Deliveries to Maintain National Security 

GlobeNewsWire - 9 months ago

NEW YORK, April 29, 2020 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced t...

GlobeNewsWire - 10 months ago

- Contract for up to $14.3 million for 15,325 Courses -

Seeking Alpha - 11 months ago

SIGA Technologies, Inc. (SIGA) CEO Phil Gomez on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 11 months ago

SIGA to supply TPOXX® To Support Turnstone’s SKV Vaccinia Oncolytic Viral Immunotherapy Program

GlobeNewsWire - 1 year ago

NEW YORK, Dec. 05, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

GlobeNewsWire - 1 year ago

NEW YORK, Nov. 18, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

GlobeNewsWire - 1 year ago

NEW YORK, Oct. 21, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

CNBC - 1 year ago

A number of Wall Street's rising hedge fund managers revealed their top stock picks at the annual Sohn San Francisco Investment Conference.

Other stocks mentioned: AFYA, BL, ADYEY
GlobeNewsWire - 1 year ago

NEW YORK, Sept. 26, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced t...

GlobeNewsWire - 1 year ago

NEW YORK, Sept. 25, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced t...

GlobeNewsWire - 1 year ago

NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced th...

About SIGA

SIGA Technologies, a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an orally administered antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was founded in 1995 and is headquartered in New York, New York.

Industry
Biotechnology
IPO Date
Sep 9, 1997
CEO
Dr. Phillip Louis Gomez III
Employees
41
Stock Exchange
NASDAQ
Ticker Symbol
SIGA
Full Company Profile

Financial Performance

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for SIGA is 11.00, which is an increase of 69.23% from the latest price.

Price Target
$11.00
(69.23% upside)